Advertisement
Clinical study| Volume 57, P131-135, November 2018

Download started.

Ok

Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease

  • Ji Eun Kim
    Affiliations
    Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea
    Search for articles by this author
  • Eungseok Oh
    Affiliations
    Department of Neurology, Chungnam National University, College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea
    Search for articles by this author
  • Jinse Park
    Affiliations
    Department of Neurology, Inje University, Haeundae Paik Hospital, Busan, Republic of Korea
    Search for articles by this author
  • Jinyoung Youn
    Affiliations
    Department of Neurology, Samsung Medical Center, College of Medicine, Sungkyunkwan University, Seoul, Republic of Korea
    Search for articles by this author
  • Ji Sun Kim
    Correspondence
    Corresponding authors at: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 135-710, Republic of Korea (J.S. Kim). Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Bangdong-ri, Sacheon-myeon, Gangneung-si, Gangwon-do 210-711, Republic of Korea (W. Jang).
    Affiliations
    Department of Neurology, Samsung Medical Center, College of Medicine, Sungkyunkwan University, Seoul, Republic of Korea
    Search for articles by this author
  • Wooyoung Jang
    Correspondence
    Corresponding authors at: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 135-710, Republic of Korea (J.S. Kim). Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Bangdong-ri, Sacheon-myeon, Gangneung-si, Gangwon-do 210-711, Republic of Korea (W. Jang).
    Affiliations
    Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea
    Search for articles by this author
Published:August 19, 2018DOI:https://doi.org/10.1016/j.jocn.2018.08.003

      Highlights

      • Mean olfactory identification score showed olfactory dysfunction in drug-naive PD.
      • Low serum 25-hydroxyvitamin D level was found in drug-naïve PD.
      • Serum vitamin D level was correlated with severity of olfactory dysfunction in PD.
      • Motor subtype of PD was significantly correlated with olfactory dysfunction in PD.

      Abstract

      The purpose of our study was to investigate the association between olfactory function in Parkinson's disease (PD) and serum vitamin D status. Thirty-nine patients with de novo PD were enrolled in this study. Olfactory function was assessed by an odor identification test, as a part of the KVSS (Korean version of sniffin’ sticks) II test. All patients were also assessed with the NMSS (Non-Motor Symptoms Scale for PD) to check the subjective change in ability to smell. Vitamin D status was determined by measuring the level of serum 25-hydroxyvitamin D3 (25-OHD3). Multiple linear regression tests and correlation analysis were applied to verify the association between serum 25-OHD3 level and patients’ subjective and objective olfactory dysfunction. The serum 25-OHD3 level was independently associated with odor identification score in patients with PD (β = 0.38, p < 0.01). Another statistically significant variable was clinical subtype of PD (Intermediate subtype: β = −0.33, p < 0.05; Akinetic rigid type: β = −0.55, p < 0.01). The serum 25-OHD3 level was also negatively correlated with the score for item number 28 in NMSS (Spearman’s rho = −0.32, p < 0.05). Our results showed that vitamin D status might be an independent factor for olfactory dysfunction in PD. Although the underlying mechanism has not been clearly identified, we postulate that vitamin D plays a role in the pathogenesis of olfactory dysfunction in PD. Further investigation to elucidate the precise relationship of vitamin D to PD is essential.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Santos-Garcia D.
        • de la Fuente-Fernandez R.
        Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
        J Neurol Sci. 2013; 332: 136-140
        • Alexander G.E.
        Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.
        Dialogues Clin Neurosci. 2004; 6: 259-280
        • Zhang S.
        • Xiao Q.
        • Le W.
        Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.
        PLoS ONE. 2015; https://doi.org/10.1371/journal.pone.0119928
        • Bohnen N.I.
        • Albin R.L.
        The cholinergic system and Parkinson disease.
        Behav Brain Res. 2011; 221: 564-573
        • Oh E.
        • Park J.
        • Youn J.
        • Kim J.S.
        • Park S.
        • Jang W.
        Olfactory dysfunction in early Parkinson's disease is associated with short latency afferent inhibition reflecting central cholinergic dysfunction.
        Clin Neurophysiol. 2017; 128: 1061-1068
        • Newmark H.L.
        • Newmark J.
        Vitamin D and Parkinson's disease–a hypothesis.
        Mov Disord. 2007; 22: 461-468
        • Buell J.S.
        • Dawson-Hughes B.
        Vitamin D and neurocognitive dysfunction: preventing “D”ecline?.
        Mol Aspects Med. 2008; 29: 415-422
        • Gil Á.
        • Plaza-Diaz J.
        • Mesa M.D.
        Vitamin D: classic and novel actions.
        Ann Nutr Metab. 2018; 72: 87-95
        • Kalueff A.V.
        • Eremin K.O.
        • Tuohimaa P.
        Mechanisms of neuroprotective action of vitamin D(3).
        Biochemistry (Mosc). 2004; 69: 738-741
        • Knekt P.
        • Kilkkinen A.
        • Rissanen H.
        • Marniemi J.
        • Saaksjarvi K.
        • Heliovaara M.
        Serum vitamin D and the risk of Parkinson disease.
        Arch Neurol. 2010; 67: 808-811
        • Kang S.Y.
        • Park S.
        • Oh E.
        • Park J.
        • Youn J.
        • Kim J.S.
        • et al.
        Vitamin D receptor polymorphisms and Parkinson's disease in a Korean population: revisited.
        Neurosci Lett. 2016; 628: 230-235
        • Li C.
        • Qi H.
        • Wei S.
        • Wang L.
        • Fan X.
        • Duan S.
        • et al.
        Vitamin D receptor gene polymorphisms and the risk of Parkinson's disease.
        Neurol Sci. 2015; 36: 247-255
        • Kwon K.Y.
        • Jo K.D.
        • Lee M.K.
        • Oh M.
        • Kim E.N.
        • Park J.
        • et al.
        Low serum vitamin D levels may contribute to gastric dysmotility in de novo Parkinson's disease.
        Neuro-degenerative Dis. 2016; 16: 199-205
        • Jang W.
        • Park J.
        • Kim J.S.
        • Youn J.
        • Oh E.
        • Kwon K.Y.
        • et al.
        Vitamin D deficiency in Parkinson's disease patients with orthostatic hypotension.
        Acta Neurol Scand. 2015; 132: 242-250
        • Hong S.C.
        • Yoo Y.S.
        • Kim E.S.
        • Kim S.C.
        • Park S.H.
        • Kim J.K.
        • et al.
        Development of KVSS Test (Korean Version of Sniffin' Sticks Test).
        Korean J Otorhinolaryngol-Head Neck Surg. 1999; 42: 855-860
        • Cho J.H.
        • Jeong Y.S.
        • Lee Y.J.
        • Hong S.C.
        • Yoon J.H.
        • Kim J.K.
        The Korean version of the Sniffin' stick (KVSS) test and its validity in comparison with the cross-cultural smell identification test (CC-SIT).
        Auris Nasus Larynx. 2009; 36: 280-286
        • Fleming S.M.
        • Tetreault N.A.
        • Mulliqan C.K.
        • Hutson C.B.
        • Masliah E.
        • Chesselet M.F.
        Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.
        Eur J Neurosci. 2008; 28: 247-256
        • Macknin J.B.
        • Hiquchi M.
        • Lee V.M.
        • Trojanowski J.Q.
        • Doty R.L.
        Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein.
        Brain Res. 2004; 1000: 174-178
        • DeLuca G.C.
        • Kimball S.M.
        • Kolasinski J.
        • Ramagopalan S.V.
        • Ebers G.C.
        Review: the role of vitamin D in nervous system health and disease.
        Neuropathol Appl Neurobiol. 2013; 39: 158-184
        • Kesby J.P.
        • Eyles D.W.
        • Burne T.H.
        • McGrath J.J.
        The effects of vitamin D on brain development and adult brain function.
        Mol Cell Endocrinol. 2011; 347: 121-127
        • Garcion E.
        • Wion-Barbot N.
        • Montero-Menei C.N.
        • Berger F.
        • Wion D.
        New clues about vitamin D functions in the nervous system.
        Trends Endocrinol Metab. 2002; 13: 100-105
        • Glaser S.D.
        • Veenstra T.D.
        • Jirikowski G.F.
        • Prüfer K.
        Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the ratolfactory system.
        Cell Mol Neurobiol. 1999; 19: 613-624
        • Huisman E.
        • Uylings H.B.
        • Hoogland P.V.
        A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
        Mov Disord. 2004; 19: 687-692
        • Tillerson J.L.
        • Caudle W.M.
        • Parent J.M.
        • Gong C.
        • Schallert T.
        • Miller G.W.
        Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor.
        Behav Brain Res. 2006; 172: 97-105
        • Özdener M.H.
        • Rawson N.E.
        Olfactory dysfunction in neurodegenerative diseases.
        Eur J Gen Med. 2004; 1: 1-11
        • Leon-Sarmiento F.E.
        • Bayona E.A.
        • Bayona-Prieto J.
        • Osman A.
        • Doty R.L.
        Profound olfactory dysfunction in myasthenia gravis.
        PLoS ONE. 2012; 7e45544https://doi.org/10.1371/journal.pone.0045544
        • Wrzosek M.
        • Łukaszkiewicz J.
        • Wrzosek M.
        • Jakubczyk A.
        • Matsumoto H.
        • Piątkiewicz P.
        • et al.
        Vitamin D and the central nervous system.
        Pharmacol Rep. 2013; 65: 271-278
        • Klimmeck D.
        • Mayer U.
        • Ungerer N.
        • Warnken U.
        • Schnölzer M.
        • Frings S.
        Calcium-signaling networks in olfactory receptor neurons.
        Neuroscience. 2008; 151: 901-912
        • Lúóng K.
        • Nguyên L.
        Role of vitamin d in Parkinson's disease.
        ISRN Neurol. 2012; 2012134289
        • Takeda A.
        • Baba T.
        • Kikuchi A.
        • Hasegawa T.
        • Sugeno N.
        • Konno M.
        • et al.
        Olfactory dysfunction and dementia in Parkinson's disease.
        J Parkinsons Dis. 2014; 4: 181-187
        • Lee E.Y.
        • Eslinger P.J.
        • Du G.
        • Kong L.
        • Lewis M.M.
        • Huang X.
        Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson’s disease.
        Mov Disord. 2014; 29: 1205-1208
        • Baba T.
        • Kikuchi A.
        • Hirayama K.
        • Nishio Y.
        • Hosokai Y.
        • Kanno S.
        • et al.
        Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.
        Brain. 2012; 135: 161-169
        • Peterson A.L.
        • Murchison C.
        • Zabetian C.
        • Leverenz J.B.
        • Watson G.S.
        • Montine T.
        • et al.
        Memory, mood, and vitamin D in persons with Parkinson's disease.
        J Parkinsons Dis. 2013; 3: 547-555
        • Stern M.B.
        • Doty R.L.
        • Dotti M.
        • Corcoran P.
        • Crawford D.
        • McKeown D.A.
        • et al.
        Olfactory function in Parkinson's disease subtypes.
        Neurology. 1994; 44: 266-268
        • Haehner A.
        • Hummel T.
        • Reichmann H.
        Olfactory loss in Parkinson's disease.
        Parkinsons Dis. 2011; 2011450939https://doi.org/10.4061/2011/450939
        • Muller A.
        • Mungersdorf M.
        • Reichmann H.
        • Strehle G.
        • Hummel T.
        Olfactory function in Parkinsonian syndromes.
        J Clin Neurosci. 2002; 9: 521-524